| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2878389 | The Annals of Thoracic Surgery | 2010 | 8 Pages |
Abstract
Clinical staging of complete response to chemoradiotherapy may not translate to pathologic complete response. Patients with ypT0N1 disease at resection have intermediate but reasonable survival, justifying an aggressive approach to curative therapy. Future revisions of the staging system should place this group of patients with patients who have metastatic regional lymph nodes, stratified by number of nodes involved.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Min P. MD, Arlene M. PhD, Jared MS, David C. MB, BCh, Jack A. MD, Reza J. MD, Garrett L. MD, Jaffer A. MD, Dipen M. MD, Joe Y. MD, PhD, Edith M. MD, Homer A. MD, Jeff H. MD, Ara A. MD, Thomas MD, Stephen G. MD, Wayne L. MD,